Stocks and InvestingStocks and Investing
Wed, February 23, 2022
Tue, February 22, 2022
Sun, February 20, 2022
Fri, February 18, 2022

Whit Mayo Maintained (AMED) at Hold with Increased Target to $147 on, Feb 18th, 2022


Published on 2024-10-27 19:45:13 - WOPRAI, Whit Mayo
  Print publication without navigation


Whit Mayo of SVB Leerink, Maintained "Amedisys, Inc." (AMED) at Hold with Increased Target from $145 to $147 on, Feb 18th, 2022.

Whit has made no other calls on AMED in the last 4 months.



There are 6 other peers that have a rating on AMED. Out of the 6 peers that are also analyzing AMED, 1 agrees with Whit's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Scott Fidel of "Stephens & Co." Maintained at Hold with Increased Target to $185 on, Thursday, November 4th, 2021


These are the ratings of the 5 analyists that currently disagree with Whit


  • Steve Valiquette of "Barclays" Maintained at Buy with Decreased Target to $213 on, Tuesday, December 21st, 2021
  • John Ransom of "Raymond James" Maintained at Buy with Decreased Target to $225 on, Monday, November 8th, 2021
  • Jonathan Yong of "Credit Suisse" Maintained at Buy with Increased Target to $205 on, Thursday, November 4th, 2021
  • Frank Morgan of "RBC Capital" Maintained at Buy with Decreased Target to $221 on, Thursday, November 4th, 2021
  • Michael Wiederhorn of "Oppenheimer" Maintained at Buy with Decreased Target to $225 on, Wednesday, November 3rd, 2021